BRKR
Get informed when a big investor buys or sells
+ FollowOvervalued by 83.8% based on the discounted cash flow analysis.
| Market cap | $8.96 Billion |
|---|---|
| Enterprise Value | $11.13 Billion |
| Dividend Yield | $0.20 (0.34%) |
| Earnings per Share | $-0.15 |
| Beta | 1.22 |
| Outstanding Shares | 152,200,000 |
| P/E Ratio | -84.18 |
|---|---|
| PEG | 10.73 |
| Price to Sales | 2.53 |
| Price to Book Ratio | 3.71 |
| Enterprise Value to Revenue | 3.18 |
| Enterprise Value to EBIT | 454.38 |
| Enterprise Value to Net Income | -157 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 0.98 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 12.34% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.03%▼ 94.36% |
|---|---|
| Total Invested | $2.54M▼ 99.97% |
| Investors Holding | 12▼ 420.00% |
No data
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable...